好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2026 Annual Meeting | C108 - Research Career Symposium

Monday 04/20/26
01:00 PM - 05:30 PM CDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Half-Day Course
Peter B. Kang, MD, FAAN, Alissa A. Thomas, MD, FAAN
好色先生, Research, and Methodology
This symposium will provide information and resources for early-career neurologists and researchers to support career paths in neurological research. Participants will gain an understanding of how to translate basic research into translational work, how to build a clinical trials portfolio, and how to approach big data. Participants will also learn strategies to formulate a career development award proposal and how to engage with the NIH.   
4.50 CME credits
Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Systems-based Practice
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Neurohospitalist, Medical Student
Didactic, Audience Participation
Event Timeline
01:00 PM - 01:05 PM CDT Introduction Welcome
Peter B. Kang, MD, FAAN
01:05 PM - 01:45 PM CDT Speaker Translational Research: Navigating Bench to Bedside
Jin M. Lee, MD, PhD
01:45 PM - 02:25 PM CDT Speaker Balancing a Clinical Trial Portfolio
Alissa A. Thomas, MD, FAAN
02:25 PM - 03:05 PM CDT Speaker How to Use Big Data in a Neurology Research Career
Peter B. Kang, MD, FAAN
03:05 PM - 03:25 PM CDT Break break
03:25 PM - 04:05 PM CDT Speaker Career Development Grants at NIH
Letitia Weigand, PhD
04:05 PM - 04:45 PM CDT Speaker Multiple Dimensions of NIH Engagement for Career Development
Nina F. Schor, MD, PhD, FAAN
04:45 PM - 05:30 PM CDT Discussion Discussion groups
Faculty Disclosures
Peter B. Kang, MD, FAAN Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurogene. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Therapeutics (Italfarmaco). An immediate family member of Dr. Kang has received personal compensation in the range of $0-$499 for serving as a Consultant for Life Sciences Consultants. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MLAB Biosciences. Dr. Kang has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Kang has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Kang has received research support from Xtraordinary Joy Foundation. The institution of an immediate family member of Dr. Kang has received research support from Sarepta Therapeutics. The institution of Dr. Kang has received research support from Centers for Disease Control and Prevention (CDC). The institution of Dr. Kang has received research support from National Institutes of Health (NIH). The institution of Dr. Kang has received research support from Food and Drug Administration. The institution of Dr. Kang has received research support from National Initiative for Cockayne Syndrome. The institution of Dr. Kang has received research support from Greg Marzolf Jr Foundation. The institution of Dr. Kang has received research support from Sarepta Therapeutics. The institution of Dr. Kang has received research support from Duchenne UK - PPMD. The institution of an immediate family member of Dr. Kang has received research support from Regenerative Medicine MN. The institution of an immediate family member of Dr. Kang has received research support from Greg Marzolf Jr Foundation. The institution of an immediate family member of Dr. Kang has received research support from NIH. The institution of an immediate family member of Dr. Kang has received research support from Viljem Julijan Association for Children with Rare Disease. The institution of Dr. Kang has received research support from Minnesota Partnership. Dr. Kang has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Kang has received intellectual property interests from a discovery or technology relating to health care. Dr. Kang has received publishing royalties from a publication relating to health care. Dr. Kang has a non-compensated relationship as a Medical Advisory Board with Speak Foundation that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a President (Including President-Elect and Past President) with Child Neurology Society that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a Board Member with Child Neurology Foundation that is relevant to AAN interests or activities.
Alissa A. Thomas, MD, FAAN The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Jin M. Lee, MD, PhD The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from Alnylam. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Council Member with NIH, NINDS.
Nina F. Schor, MD, PhD, FAAN Dr. Schor has received publishing royalties from a publication relating to health care. Dr. Schor has received personal compensation in the range of $100,000-$499,999 for serving as a Deputy Director for Intramural Research with National Institutes of Health.
Letitia Weigand, PhD Letitia Weigand, PhD has received personal compensation for serving as an employee of UCB.